BIOCARDIA INC (BCDA)

US09060U5074 - Common Stock

0.3799  +0 (+1.31%)

After market: 0.375 0 (-1.29%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
1.02M
580.00%		1.35M
32.35%		477K
-64.67%		357K
-25.16%
EBITDA
YoY % growth
-12.57M
18.69%		-11.82M
5.97%		-11.56M
2.20%		-16.32M
-41.18%
EBIT
YoY % growth
-12.63M
18.67%		-11.9M
5.78%		-11.644M
2.15%		-17.656M
-51.63%
Operating Margin
-1,238.24%-881.48%-2,441.09%-4,945.57%
EPS
YoY % growth
-0.74
53.16%		-0.67
9.46%		-0.55
17.91%		-0.58
-4.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.20
-20.00%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.09
43.75%		-0.110.0219.79%
Q3 2023
Q2Q % growth		 -0.12
29.41%		-0.120.001.96%
Q2 2023
Q2Q % growth		 -0.17
-21.43%		-0.16-0.01-6.38%
Q1 2023
Q2Q % growth		 -0.17
15.00%		-0.16-0.01-4.17%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 13K
-88.18%		96.9K-83.9K-86.58%
Q3 2023
Q2Q % growth		 360K
71.43%		25.5K334.5K1,311.76%
Q2 2023
Q2Q % growth		 40K
-95.88%		124.777K-84.777K-67.94%
Q1 2023
Q2Q % growth		 60K 346.8K-286.8K-82.70%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% -34.52%
RevenueN/A N/A 0% 0%